Biotech · Private company
Nuvelution TS Pharma, Inc.
Track this companyFree. Adds Nuvelution TS Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials3
- A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)PHASE3 · COMPLETED · started May 31, 2018ClinicalTrials.gov NCT03571256 · fetched Nov 12, 2026
- Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and AdolescentsPHASE3 · TERMINATED · started May 25, 2018ClinicalTrials.gov NCT03567291 · fetched Nov 12, 2026
- Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and AdolescentsPHASE2_PHASE3 · COMPLETED · started Feb 5, 2018ClinicalTrials.gov NCT03452943 · fetched Nov 12, 2026